Brief: Alligator Is Exploring Financing Alternatives

Alligator Bioscience AB

02/09/2021 11:03

Sept 2 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ALLIGATOR IS EXPLORING FINANCING ALTERNATIVES TO SUPPORT
PHASE
II STUDIES FOR MITAZALIMAB, PHASE II PREPARATIONS FOR ATOR-1017
AS WELL AS THE DEVELOPMENT OF OTHER PIPELINE
    * WILL BEGIN EVALUATING POTENTIAL FINANCING ALTERNATIVES,
WHICH
MAY INCLUDE ISSUANCE OF EQUITY
    * BOARD'S CURRENT ASSESSMENT IS THAT WORKING CAPITAL WILL
NEED TO
BE STRENGTHENED IN ORDER TO ENABLE PHASE II STUDIES FOR
MITAZALIMAB, PHASE II PREPARATIONS FOR ATOR-1017 AS WELL AS
DEVELOPMENT OF OTHER PIPELINE CANDIDATES AND GENERAL CORPORATE
PURPOSES

Source text for Eikon:  ID:nWkr8vsmst 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))